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1726-4Sleep disorders in pregnancyA recent epidemiologic study with a small sample size
(n ¼ 248) in southern Taiwan suggested that the prevalence of
poor sleepers (Pittsburgh Sleep Quality Index score > 5) was
58% for second-trimester women and 66% for third-trimester
women. The study also showed that women who were
unemployed reported significantly higher prevalence of poor
sleep quality than those who were employed.1
Sleep disturbance, a substantial health problem, is defined
as either short or long sleep duration with associated poor
sleep quality or continuity, which may be related to a sleep
disorder. This can result in alterations in mental functioning,
diminished daytime functioning, depression, hypertension, and
diabetes. The phenomenon of sleep disturbance has also
received considerable attention because evidence indicates
that sleep disturbance is associated with adverse maternal and
neonatal outcomes when occurring during pregnancy, includ-
ing low birth weight, intrauterine growth retardation, preterm
birth, and operative birth.2 Sleep disturbance is associated with
neuroendocrine, metabolic, and inflammatory changes2;
therefore, we are pleased to be in the position to comment on
the article of Gunduz et al,3 entitled Sleep disturbance in the
last trimester of pregnancy and inadequate vitamin D: is there
a relationship?, published in the current issue of the Journal of
the Chinese Medical Association. Furthermore, we wish to
more widely introduce this relatively common and important
issuedsleep disturbance, which is often neglected in the
routine of clinical practice.
First, similar to the report from southern Taiwan, the
median value of the Pittsburgh Sleep Quality Index score was
a high of 6.2, and the prevalence of Turkish women with sleep
disturbance was estimated to be 43.5%.3 Both showed that
sleep disturbance is extremely common in pregnant women.
The authors tried to investigate the relationship between sleep
disturbance and serum level of vitamin D in pregnant women, but
found an absence of any association. The discussion of vitamin D
is often limited to calcium homeostasis, especially on issues of
bone health,4,5 althoughmore recent knowledgemight expand the
conversation to cover cardiovascular, neurological, dermatologic,
and immunologic systems, and possibly neoplasm therapy.
Vitamin D rarely involves or is associated with psychiatric
problems, including sleep disorders. Therefore, it is not surprising
that the authors would obtain the negative report of absence ofx.doi.org/10.1016/j.jcma.2015.06.002
901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Assassociation between sleep disorders and inadequate vitamin D.3
Based on the results of the authors, it would be interesting to
know whether there really is an absence of association between
sleep disorders and inadequate vitamin D. We highlight this
question based on the following. In Taiwan, sleep disorders and
sleep-related breathing disorders are common in hemodialysis
patients,6 although we were not aware of any vitamin D as cau-
sation or association for sleep disturbance in hemodialysis
patients. However, the publication did hint at the possibility. In
fact, sleep disturbance is a complicated disease, which can be
separated into at least three subgroups, including sleep-disordered
breathing (habitual snoring and obstructive sleep apnea), restless
legs syndrome, and pure types of insomnia. Therefore, without a
clear demonstration of what types of sleep disturbances are in the
current study, it is difficult to make the conclusion.
Second, we would like to introduce sleep disturbance in
pregnancy. The topic of sleep disorder in pregnant women is
seldom reported in Taiwan, and any discussion and education
on the issue is extremely rare. Although the reasons for this
omission are unknown, it may be secondary to a general
unfamiliarity with the diagnosis and management of pregnant
women with sleep disturbance. Of course, the other possibility
is that obstetricians have frequently just neglected this disorder
and instead were more inclined to use sleep-promoting medi-
cations. A recent review by Okun et al7 reported that medi-
cations, including benzodiazepines, hypnotic benzodiazepine
receptor agonists, antidepressants, and antihistamines, did not
show any correlation of increased risk of congenital malfor-
mations, however, benzodiazepines and hypnotic benzodiaze-
pine receptor agonists may increase rates of preterm birth, low
birth weight, and/or small-for-gestational-age infants. The
results from a recent nationwide population-based study in
Taiwan could provide a further reference of value.8 Wang et al8
compared the risk of adverse pregnancy outcomes in 2497
women who received zolpidem (hypnotic benzodiazepine
receptor agonists, pregnancy category C) and 12,485 randomly
selected mothers who did not receive the drug. The results
showed that the adjusted odds ratios (OR) for adverse preg-
nancy outcomes, including low birth weight infants, preterm
births, small-for-gestational-age infants, and cesarean delivery,
were all higher in mothers who received zolpidem treatment
during pregnancy relative to the randomly selected controls,ociation. All rights reserved.
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1.49 (95% CI 1.28e1.74), 1.34 (95% CI 1.20e1.49), and 1.74
(95% CI 1.59e1.90), respectively. Therefore, the authors
concluded that the risk of adverse pregnancy outcomes was
higher in pregnant women treated with zolpidem than in those
without similar treatment.8 Based on the above-mentioned
report, benzodiazepines (pregnancy category D) and hypnotic
benzodiazepine receptor agonists (pregnancy category C)
should be used cautiously in pregnant women.
Finally, because antihistamines are highly soporific, which
makes them desirable for pregnancy-related sleep dis-
turbances, and it has been reported that approximately 92% of
pregnant women occasionally self-treat with over-the-counter
sleep aids, in particular diphenhydramine (pregnancy cat-
egory B) and doxylamine (pregnancy category A),9 antihist-
amines might be an alternative choice.
In conclusion, sleep disturbance during pregnancy could be
an important health issue, although it is often missed. There is
currently no prescription protocol that exists for the treatment
of sleep problems in pregnancy.7 To avoid the potential ter-
atogenic effect, obstetricians might consider using non-
pharmacologic treatments to address sleep complaints,
including cognitive behavioral treatment for insomnia and
exercise. Ultimately, antihistamines may be one of the best
choices of medication, however, no studies have confirmed the
efficacy of their use for sleep complaints. More research is
needed to investigate more carefully the treatment of sleep
disturbance in pregnancy.
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